Exploring biomarkers associated with severity of knee osteoarthritis in Southern China using widely targeted metabolomics.

BACKGROUND: Metabolomics is a tool to study the pathogenesis of diseases and their associated metabolites, but there are still insufficient metabolomic studies on severe knee osteoarthritis.To investigate the differences in serum metabolites between healthy populations and knee osteoarthritis (KOA) patients in Southern China using widely targeted metabolomics, and to explore biomarkers and their metabolic pathways that could be associated with the severity of KOA. METHODS: There were 10 healthy individuals in the control group and 32 patients with KOA. According to the Kellgren-Lawrence (KL) grading system, KOA was further divided into mild (n = 13, KL grade 1 and 2) and severe (n = 19, KL grade 3 and 4). Serum samples from all participants were collected and analyzed metabolomics based on ultra-performance liquid chromatography/electrospray ionization/tandem mass spectrometry. We screened for differential metabolites between patients and controls, and between mild and severe KOA. We explored the metabolic pathways involved in differential metabolism using the Kyoto Encyclopedia of Genes and Genomes database. RESULTS: Sixty-one metabolites were differentially expressed in the sera of the patient group compared with the control group (45 upregulated and 16 downregulated). Analysis of the mild and severe KOA groups showed a total of 12 differential metabolites. Receiver operating characteristic curve analysis showed N-alpha-acetyl-L-asparagine was a good predictor of advanced osteoarthritis(OA).Differential metabolites are enriched in multiple pathways such as arachidonic acid metabolism. CONCLUSION: Widely targeted metabolomics found that upregulation of the amino acid metabolite N-α-acetyl-L-asparagine was significantly associated with severe KOA and could be a biomarker for predicting severity of KOA. Arachidonic acid metabolism may play an important role in patients with severe KOA.

Self-Host Blue-Emitting Iridium Dendrimer Containing Bipolar Dendrons for Nondoped Electrophosphorescent Devices with Superior High-Brightness Performance.

A novel self-host blue-emitting iridium dendrimer, namely, B-CzPO, has been designed and synthesized via a postdendronization route, where a bipolar carbazole/triphenylphosphine oxide hybrid is selected as the peripheral dendron instead of the p-type oligocarbazole used in unipolar analogue B-CzG2. This structural modification can render B-CzPO with more balanced charge transportation relative to that of B-CzG2. As a result of the significantly reduced efficiency roll-off, the nondoped phosphorescent organic light-emitting diodes (PhOLEDs) of B-CzPO show a superior high-brightness performance, revealing a luminous efficiency of 21.2, 16.1, and 10.5 cd/A at 1000, 5000, and 10 000 cd/m2, respectively. Compared with that of B-CzG2 (i.e., 7.8 cd/A @5000 cd/m2), more than doubled high-brightness performance is achieved for B-CzPO. The results indicate that the design of self-host phosphorescent dendrimers with a bipolar feature will be a promising strategy to develop efficient nondoped PhOLEDs suitable for high-brightness applications including general illumination and micro displays.

Single molecular tuning of the charge balance in blue-emitting iridium dendrimers for efficient nondoped solution-processed phosphorescent OLEDs.

The single molecular tuning of charge balance has been demonstrated here by integrating a p-type dendron, an n-type dendron and a blue emissive Ir core into one dendritic platform. Compared with the commonly used physical blending, not only can the charge balance be well tailored, but also the intrinsic phase separation can be successfully eliminated in such developed single molecular systems (B-TCz2TPO1 and B-TCz1TPO2). As a consequence, their corresponding nondoped solution-processed PhOLEDs achieve more than doubled external quantum efficiencies accompanied by a negligible efficiency roll-off.